Request Deal Involvement
Revolution Medicines completed the acquisition of EQRx for $1.1bn.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
financial advisors
Goldman Sachs
financial advisors
MTS Health Partners
legal advisors
Goodwin Procter
pr advisors
FGS Global
legal advisors to financial advisors
Sullivan & Cromwell
legal advisors to financial advisors
Cooley
financial advisors
Guggenheim Partners
legal advisors
Latham & Watkins
pr advisors
H/Advisors Abernathy
or
Principals
target
EQRX
bidder
REVOLUTION MEDICINES INC
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite